Genicon Revenue and Competitors
Estimated Revenue & Valuation
- Genicon's estimated annual revenue is currently $3.3M per year.
- Genicon's estimated revenue per employee is $251,000
Employee Data
- Genicon has 13 Employees.
- Genicon grew their employee count by -38% last year.
Genicon Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.1M | 104 | 0% | $63.5M | N/A |
#2 | $14.3M | 57 | -8% | N/A | N/A |
#3 | $33.1M | 132 | 6% | N/A | N/A |
#4 | $10.8M | 43 | 5% | N/A | N/A |
#5 | $488.3M | 1216 | 0% | N/A | N/A |
#6 | $14.3M | 57 | 10% | N/A | N/A |
#7 | $5M | 20 | -9% | N/A | N/A |
#8 | $95.6M | 381 | -1% | N/A | N/A |
#9 | $16.8M | 67 | 3% | N/A | N/A |
#10 | $57M | 227 | 13% | N/A | N/A |
What Is Genicon?
GENICON is recognized as an emerging leader in the design, production, and distribution of patented surgical instrumentation focused exclusively on laparoscopic surgery. Founded in 1998 and based in Orlando, Florida, GENICON is a privately held firm in which several of our shareholders are surgeons who utilize our products. GENICON remains today as it originated: a company driven to meet the needs of modern-day healthcare through the harmonization of clinical needs and the economic demands of a global healthcare system.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$3.3M
Revenue (est)
-38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Genicon News
Aesculap, Inc. (B. Braun Melsungen AG), Genicon Inc., Xion GmbH, LaproSurge Ltd., Peters Surgical, Teleflex Incorporated, Conmed Corporation...
... Ethicon, Teleflex Incorporated, Olympus, Grena Think Medical, Applied Medical Resources Corporation, Genicon, Medtronic, ConMed.
Ethicon, GENICON, Maxer, Unimax Medical, VECTEC, Dr.Fritz, Vomed, WISAP Medical, Grena, Lagis Endosurgical, Lapro Surge, Metromed Healthcare.
Other Companies in Winter Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 13 | -19% | N/A |
#2 | $1.4M | 13 | 18% | N/A |
#3 | $1.4M | 15 | 15% | N/A |
#4 | $2.6M | 15 | 0% | N/A |
#5 | $2.6M | 17 | 6% | N/A |